These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2695948)

  • 1. Singlet oxygen induced mutagenesis of benzo[a]pyrene derivatives.
    Seed JL; Specht KG; Dahl TA; Midden WR
    Photochem Photobiol; 1989 Nov; 50(5):625-32. PubMed ID: 2695948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutagenicity of some methylated benzo[a]pyrene derivatives.
    Santella R; Kinoshita T; Jeffrey AM
    Mutat Res; 1982; 104(4-5):209-13. PubMed ID: 6287248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pure exogenous singlet oxygen: nonmutagenicity in bacteria.
    Dahl TA; Midden WR; Hartman PE
    Mutat Res; 1988 Sep; 201(1):127-36. PubMed ID: 3047571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfite-dependent mutagenicity of benzo[a]pyrene derivatives.
    Reed GA
    Carcinogenesis; 1987 Aug; 8(8):1145-8. PubMed ID: 3301047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenicity of the bay-region diol-epoxides and other benzo-ring derivatives of dibenzo(a,h)pyrene and dibenzo(a,i)pyrene.
    Wood AW; Chang RL; Levin W; Ryan DE; Thomas PE; Lehr RE; Kumar S; Sardella DJ; Boger E; Yagi H; Sayer JM; Jerina DM; Conney AH
    Cancer Res; 1981 Jul; 41(7):2589-97. PubMed ID: 7018665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic activation to a mutagen of 3-hydroxy-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene, a secondary metabolite of benzo[a]pyrene.
    Glatt H; Seidel A; Ribeiro O; Kirkby C; Hirom P; Oesch F
    Carcinogenesis; 1987 Nov; 8(11):1621-7. PubMed ID: 3311446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenicity of benzo[a]pyrene bay-region sulfonates.
    Green JL; Pan YH; Reed GA
    Carcinogenesis; 1991 Jul; 12(7):1359-62. PubMed ID: 1906381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the cytotoxicity and mutagenicity of benzo[a]pyrene and benzo[a]pyrene 7,8-diol by glutathione and glutathione S-transferases in mammalian cells (CHO/HGPRT assay).
    Recio L; Hsie AW
    Mutat Res; 1987 Jun; 178(2):257-69. PubMed ID: 3587256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host-mediated mutagenicity experiments with benzo[a]pyrene and two of its metabolites.
    Glatt H; Bücker M; Platt KL; Oesch F
    Mutat Res; 1985 Jun; 156(3):163-9. PubMed ID: 3889634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photobiological activities of 1,6-dioxapyrene in pro- and eukaryotic cells.
    Averbeck D; Polasa K; Buisson JP; Bensasson R; Rougée M; Cadet J; Ravanat JL; Perin F; Vigny P; Demerseman P
    Mutat Res; 1993 Jun; 287(2):165-79. PubMed ID: 7685477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro inhibition of the metabolism and mutagenicity of benzo(a)pyrene and benzo(a)pyrene-7,8-dihydrodiol by naphthazarin and other naphthol derivatives.
    Espino PC; Sullivan PD
    Biochem Biophys Res Commun; 1987 Feb; 142(3):939-46. PubMed ID: 2435285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rat hepatocyte-mediated bacterial mutagenicity in relation to the carcinogenic potency of benz(a)anthracene, benzo(a)pyrene, and twenty-five methylated derivatives.
    Utesch D; Glatt H; Oesch F
    Cancer Res; 1987 Mar; 47(6):1509-15. PubMed ID: 3545447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological inactivation by singlet oxygen: distinguishing O2(1 delta g) and O2(1 sigma g+).
    Midden WR; Dahl TA
    Biochim Biophys Acta; 1992 Sep; 1117(2):216-22. PubMed ID: 1525183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotoxicity studies with mineral oils; effects of oils on the microbial mutagenicity of precursor mutagens and genotoxic metabolites.
    Watson WP; Brooks TM; Gonzalez LP; Wright AS
    Mutat Res; 1985 Apr; 149(2):159-70. PubMed ID: 3920514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between benzo(a)pyrene-induced DNA base modification and frequency of reverse mutations in mutant strains of Salmonella typhimurium.
    Fahl WE; Scarpelli DG; Gill K
    Cancer Res; 1981 Sep; 41(9 Pt 1):3400-6. PubMed ID: 6266655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumorigenicity and liver tumor ras-protooncogene mutations in CD-1 mice treated neonatally with 1- and 3-nitrobenzo[a]pyrene and their trans-7,8-dihydrodiol and aminobenzo[a]pyrene metabolites.
    Von Tungeln LS; Xia Q; Bucci T; Heflich RH; Fu PP
    Cancer Lett; 1999 Apr; 137(2):137-43. PubMed ID: 10374834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of the potency of promutagens and direct acting mutagens in bacteria by inhibitors of the multidrug resistance mechanism.
    De Flora S; Camoirano A; Cartiglia C; Ferguson L
    Mutagenesis; 1997 Nov; 12(6):431-5. PubMed ID: 9412996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some chloro derivatives of polynuclear aromatic hydrocarbons are potent mutagens in Salmonella typhimurium.
    Colmsjö A; Rannug A; Rannug U
    Mutat Res; 1984 Jan; 135(1):21-9. PubMed ID: 6363910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced mutation spectra at the upp locus in Salmonella typhimurium: response of the target gene in the FU assay to mechanistically different mutagens.
    Vlasakova K; Skopek TR; Glaab WE
    Mutat Res; 2005 Oct; 578(1-2):225-37. PubMed ID: 16143350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical models for cytochrome P450 as a biomimetic metabolic activation system in mutation assays.
    Inami K; Mochizuki M
    Mutat Res; 2002 Aug; 519(1-2):133-40. PubMed ID: 12160898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.